DelMar Pharmaceuticals, Inc. | Purchase Agreements | Business Contracts

Purchase Agreement, dated as of August 2, 2022, by and between Kintara Therapeutics, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on August 3, 2022)

Form of Securities Purchase Agreement, dated April 12, 2022, by and between Kintara Therapeutics, Inc. and the purchasers named therein (Filed With SEC on April 13, 2022)

Form of Securities Purchase Agreement, dated September 23, 2021 (Filed With SEC on September 28, 2021)

Asset Purchase Agreement, dated as of November 26, 2012, by and between Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC (Filed With SEC on June 16, 2020)

Amendment to Asset Purchase Agreement, dated as of May 12, 2014, by and between Adgero Biopharmaceuticals, Inc. and St. Cloud Investments, LLC (Filed With SEC on June 16, 2020)

Form of Purchase Agreement, dated as of June 3, 2019 among DelMar Pharmaceuticals, Inc. and the purchasers thereunder (Filed With SEC on June 3, 2019)

DelMar Pharmaceuticals, Inc. (55) | Purchase Agreements (6)